(408) 747-0185

PLCG1 (Phospho-Tyr771) Antibody

Catalog No : A0079
  • Applications
    WB, IHC, ELISA
  • Reactivity
    Human, Mouse, Rat
  • Size
    50ul
  • Price
    $195.00
Anti-PLCG1 (Phospho-Tyr771) polyclonal Antibody detects PLCG1 only when phosphorylated at Tyr771. Validated for WB, IHC and ELISA. Reactive for Human, Mouse, Rat. AssayBiotechnology an original antibody manufacturer.
Details
  • Product Name
    PLCG1 (Phospho-Tyr771) Antibody
  • Catalog No
    A0079
  • Storage/Stability
    Stable at -20°C for at least 1 year.
  • Applications
    WB, IHC, ELISA
  • Clonality
    Polyclonal
  • Host Species
    Rabbit
  • Reactivity
    Human, Mouse, Rat
  • Application Dilutions
    WB: 1:500~1:1000 IHC: 1:50~1:100 ELISA: 1:40000
  • Database Links
    Gene ID: 5335, Swiss-Prot #: P19174, OMIM #: 172420, Unigene #: Hs.268177
  • Immunogen
    The antiserum was produced against synthesized peptide derived from human PLCG1 around the phosphorylation site of Tyr771.
  • Immunogen Range
    736-785
  • Modification Sites
    H: Y771 M: Y771 R: Y771
  • MW
    148 kDa
  • NCBI Gene Symbol
    PLCG1
  • Physical Form
    Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
  • Purification
    The antibody was purified from rabbit antiserum by affinity-chromatography using phospho peptide. The antibody against non-phospho peptide was removed by chromatography using corresponding non-phospho peptide.
  • Specificity
    PLCG1 (Phospho-Tyr771) Antibody detects endogenous levels of PLCG1 only when phosphorylated at Tyr771.
  • Synonyms
    1-phosphatidylinositol-4, 5-bisphosphate phosphodiesterase gamma-1, PLC-148, Phosphoinositide phospholipase C-gamma-1, Phospholipase C-II, PLC-II, Phospholipase C-gamma-1, PLC-gamma-1 , PLCG1, PLC1
  • Target Modification
    Phospho
Application Images
Western blot analysis of lysates from COS7 cells treated with EGF 200ng/ml 30', using PLCG1 (Phospho-Tyr771) Antibody. The lane on the right is blocked with the phospho peptide.
Immunohistochemistry analysis of paraffin-embedded human breast carcinoma, using PLCG1 (Phospho-Tyr771) Antibody. The picture on the right is blocked with the phospho peptide.
Western Blot analysis of various cells using Phospho-PLC gamma1 (Y771) Antibody
Immunohistochemical analysis of paraffin-embedded Human breast cancer. Antibody was diluted at 1:100(4°,ON). Negative control (right) obtaned from antibody was pre-absorbed by immunogen peptide.
Immunohistochemical analysis of paraffin-embedded Human breast cancer. Antibody was diluted at 1:100(4°,ON). Negative control (right) obtaned from antibody was pre-absorbed by immunogen peptide.
Western blot analysis of lysates from COS7 cells treated with EGF 200ng/ml 30', using PLCG1 (Phospho-Tyr771) Antibody. The lane on the right is blocked with the phospho peptide.
Immunohistochemistry analysis of paraffin-embedded human breast carcinoma, using PLCG1 (Phospho-Tyr771) Antibody. The picture on the right is blocked with the phospho peptide.
Western Blot analysis of various cells using Phospho-PLC gamma1 (Y771) Antibody
Immunohistochemical analysis of paraffin-embedded Human breast cancer. Antibody was diluted at 1:100(4°,ON). Negative control (right) obtaned from antibody was pre-absorbed by immunogen peptide.
Immunohistochemical analysis of paraffin-embedded Human breast cancer. Antibody was diluted at 1:100(4°,ON). Negative control (right) obtaned from antibody was pre-absorbed by immunogen peptide.